General Manager Greece, IQVIA

Nikos joined IMS in 2009 as Head of Sales and Marketing to help build the new sales team and strengthen the client-centric approach of IMS Health commercial team.

In 2014, he assumed the role of the General Manager and, after the acquisition of Cegedim and the merger with Quintiles, global leader in clinical trials, he leads the company under its new name IQVIA. IQVIA offers various solutions in:

a) Data, for Pharmacy Retail sell-out, E-Prescription, and Hospitals drug consumption,

b) Consulting, with Advanced Analytics, Management Consulting, HTA, RWE, Market Research,

c) Technology, with CRM, BI systems and Multi-Channel Marketing and

d) Clinical Trials.

The latest accomplishment of IQVIA Greece, under Nikos leadership, is the HQ decision to establish in Athens three regional hubs for:

a) Technology,

b) Health Economics and

c) Management Consulting.

Aiming to hire more than 43 top professionals till 2021-end, IQVIA Greece materializes in practice the brain-gain effort, helps bring income to Greece and improves day by day the trust to our country. Furthermore, 2020 was a record year with 50 new hires!

Nikos working experience covers multinational enterprises in various sectors such as consumer goods, pharmaceuticals, financial-economic and services. Since 1994 he held neuralgic positions as Marketing and National Sales Manager, in Greece and Italy, at global organizations such as Mars, Procter & Gamble and Novartis OTC, with a history of successful and award-winning launches. His main areas of expertise relate to strategy, business development, commercial effectiveness, planning, product management and people leadership.

Nikos is a graduate of the University of Piraeus and holds an MBA from ALBA. His native language is Greek and he is fluent in English and Italian.

 

IQVIA Profile

As a result of the merger of IMS Health, a world leader in data analysis & technology solutions exclusively in the field of Health, and Quintiles, one of the world’s leading companies in Clinical Studies, IQVIA, based in the USA, has a presence in 100+ countries with 75K employees.

In Greece, we have been active since 1968, counting now more than 200 employees and collaborating with all Healthcare professionals as well as Hospitals. In numerical terms, IQVIA Hellas has a network of 3.5K doctors and 3K pharmacies for data collection & primary research studies, while conducting at least 120 clinical studies at over 100 sites.

We also work closely with all partners in Healthcare ecosystem, such as institutions, authorities, collective bodies of health scientists and pharmaceutical companies, as well as patient associations, providing our services to over 150 clients.

Rescheduling of the Major Event with Caroline Myss
to April 25 & 26, 2026

The Leading Minds organization announces the rescheduling of the highly anticipated event with Caroline Myss, originally planned for November 22 & 23, 2025, to the new dates of April 25 & 26, 2026, at the same venue.

This change comes following notification from Caroline Myss herself, who faced an unexpected health issue that requires her to temporarily postpone all her international appearances.

Caroline Myss looks forward to meeting the Greek audience in April 2026, fully renewed, for an experience that will be even more meaningful and transformative.

All tickets that have already been issued remain valid for the new dates, with no further action required from participants.

The Leading Minds organization expresses its deep gratitude for the trust, support, and understanding of the audience and all collaborators, and remains committed, as always, to providing meaningful and transformative experiences.

See you on April 25 & 26, 2026!

For more information:

🌐 www.leadingminds.gr
📧 [email protected]

The Leading Minds Organization

Μεταφορά του μεγάλου event με την Caroline Myss στις 25 & 26 Απριλίου 2026

Η διοργάνωση του Leading Minds ανακοινώνει τη μεταφορά της πολυαναμενόμενης εκδήλωσης με την Caroline Myss, που ήταν προγραμματισμένη για τις 22 & 23 Νοεμβρίου 2025, στις νέες ημερομηνίες 25 & 26 Απριλίου 2026, στον ίδιο χώρο.

Η αλλαγή αυτή πραγματοποιείται έπειτα από ενημέρωση της ίδιας της Caroline Myss, η οποία αντιμετώπισε ένα έκτακτο ζήτημα υγείας που την υποχρεώνει να αναβάλει προσωρινά όλες τις διεθνείς εμφανίσεις της.

Η Caroline Myss ανυπομονεί να συναντήσει το ελληνικό κοινό τον Απρίλιο του 2026, πλήρως ανανεωμένη, για μια εμπειρία ακόμη πιο ουσιαστική και μεταμορφωτική.

Όλα τα εισιτήρια που έχουν ήδη εκδοθεί παραμένουν σε ισχύ για τις νέες ημερομηνίες, χωρίς καμία επιπλέον ενέργεια από τους συμμετέχοντες.

 Η διοργάνωση Leading Minds εκφράζει τη βαθιά της ευγνωμοσύνη για την εμπιστοσύνη, τη στήριξη και την κατανόηση του κοινού και όλων των συνεργατών της, και δεσμεύεται, όπως πάντα, να προσφέρει εμπειρίες ουσιαστικές και μεταμορφωτικές.  

Ραντεβού στις 25 & 26 Απριλίου 2026! 

Για περισσότερες πληροφορίες:

🌐 www.leadingminds.gr
📧 [email protected]

Η διοργάνωση του Leading Minds